Ratings by Goldman Sachs (Salveen Richter)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/24/2021 | TCR2 Therapeutics | TCRR | New Coverage | Buy (N/A) |
17.24 (17.81) |
3.31% | Details | |
| 6/22/2021 | Centessa Pharmaceuticals | CNTA | New Coverage | Buy (N/A) |
24.91 (23.75) |
-4.66% | Details | |
| 5/24/2021 | Reata Pharmaceuticals | RETA | New Coverage | Buy (N/A) |
111.60 (147.96) |
32.58% | Details | |
| 5/20/2021 | Precision BioSciences Inc. | DTIL | Maintain | Neutral (N/A) |
|
Details | ||
| 5/14/2021 | 4D Molecular Therapeutics | FDMT | Maintain | Neutral (N/A) |
|
Details | ||
| 5/11/2021 | Recursion Pharmaceuticals | RXRX | New Coverage | Neutral (N/A) |
27.73 (34.76) |
25.35% | Details | |
| 5/10/2021 | Amicus Therapeutics | FOLD | Maintain | Neutral (N/A) |
|
Details | ||
| 5/4/2021 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2021 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2021 | Agios Pharma | AGIO | New Coverage | Neutral (N/A) |
55.78 (57.10) |
2.37% | Details | |
| 4/29/2021 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 4/6/2021 | Acadia Pharmaceuticals | ACAD | Downgrade | Neutral (Buy) |
25.59 (25.05) |
-2.11% | Details | |
| 3/28/2021 | 4D Molecular Therapeutics | FDMT | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/25/2021 | Sana Biotechnology | SANA | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/18/2021 | Precision BioSciences Inc. | DTIL | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2021 | Taysha Gene Therapies | TSHA | Maintain | Buy (Buy) |
|
Details | ||
| 3/4/2021 | Passage Bio Inc. | PASG | Upgrade | Buy (Neutral) |
19.59 (14.12) |
-27.92% | Details | |
| 3/3/2021 | Adeptus Biotechnologies Corp. | ADPT | Downgrade | Neutral (Buy) |
53.11 (39.70) |
-25.25% | Details | |
| 3/2/2021 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | uniQure BV | QURE | Maintain | Buy (Buy) |
|
Details | ||
| 3/1/2021 | Madrigal Pharmaceuticals | MDGL | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/1/2021 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (Buy) |
|
Details | ||
| 3/1/2021 | Sana Biotechnology | SANA | New Coverage | Neutral (N/A) |
32.05 (20.21) |
-36.94% | Details | |
| 2/26/2021 | Mirati Therapeutics | MRTX | Maintain | Buy (Buy) |
|
Details | ||
| 2/26/2021 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2021 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2021 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2021 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2021 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2021 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 12/21/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/24/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Neutral (N/A) |
|
Details | ||
| 11/17/2020 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2020 | Cellectis | CLLS | Maintain | Sell (N/A) |
|
Details | ||
| 11/6/2020 | Madrigal Pharmaceuticals | MDGL | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2020 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2020 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 10/21/2020 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 10/19/2020 | Taysha Gene Therapies | TSHA | New Coverage | Neutral (N/A) |
21.05 (25.19) |
19.67% | Details | |
| 10/16/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 9/21/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2020 | Intellia Therapeutics | NTLA | New Coverage | Buy (N/A) |
22.45 (85.46) |
280.67% | Details | |
| 9/8/2020 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 8/19/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 8/13/2020 | Precision BioSciences Inc. | DTIL | Maintain | Neutral (N/A) |
|
Details | ||
| 8/11/2020 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Relay Therapeutics | RLAY | New Coverage | Buy (N/A) |
41.02 (35.61) |
-13.19% | Details | |
| 8/6/2020 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2020 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2020 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2020 | Intercept Pharmaceuticals | ICPT | Downgrade | Neutral (Buy) |
77.49 (21.18) |
-72.67% | Details | |
| 6/25/2020 | Passage Bio Inc. | PASG | Downgrade | Neutral (Buy) |
36.07 (14.12) |
-60.85% | Details | |
| 6/3/2020 | Adeptus Biotechnologies Corp. | ADPT | New Coverage | Buy (N/A) |
39.07 (39.70) |
1.61% | Details | |
| 6/1/2020 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/29/2020 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 5/26/2020 | Incyte | INCY | Downgrade | Buy (Conviction Buy) |
99.37 (85.41) |
-14.05% | Details | |
| 5/26/2020 | Seattle Genetics | SGEN | Upgrade | Conviction Buy (Buy) |
155.77 (156.26) |
0.31% | Details | |
| 5/18/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2020 | Arrowhead Research | ARWR | Maintain | Neutral (N/A) |
|
Details | ||
| 4/28/2020 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 4/21/2020 | Madrigal Pharmaceuticals | MDGL | Maintain | Neutral (N/A) |
|
Details | ||
| 4/16/2020 | Mirati Therapeutics | MRTX | New Coverage | Buy (N/A) |
85.32 (165.90) |
94.44% | Details | |
| 4/3/2020 | Precision BioSciences Inc. | DTIL | Downgrade | Neutral (Buy) |
5.27 (11.30) |
114.42% | Details | |
| 3/31/2020 | Acadia Pharmaceuticals | ACAD | Upgrade | Buy (Neutral) |
38.83 (25.59) |
-34.1% | Details | |
| 3/26/2020 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2020 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2020 | Arrowhead Research | ARWR | New Coverage | Neutral (N/A) |
26.32 (89.23) |
239.02% | Details | |
| 3/6/2020 | Cellectis | CLLS | Downgrade | Sell (Neutral) |
15.74 (15.42) |
-2.03% | Details | |
| 2/28/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2020 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2020 | Intercept Pharmaceuticals | ICPT | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2020 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 2/14/2020 | Agios Pharma | AGIO | Maintain | Neutral (N/A) |
|
Details | ||
| 2/13/2020 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 2/11/2020 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Neutral (N/A) |
|
Details | ||
| 1/27/2020 | Denali Therapeutics Inc. | DNLI | Upgrade | Buy (Neutral) |
24.90 (73.80) |
196.39% | Details | |
| 1/3/2020 | Incyte | INCY | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 12/24/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2019 | uniQure BV | QURE | New Coverage | Buy (N/A) |
54.78 (30.19) |
-44.89% | Details | |
| 11/21/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Neutral (N/A) |
|
Details | ||
| 11/19/2019 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 11/18/2019 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2019 | Solid Biosciences | SLDB | Maintain | Sell (N/A) |
|
Details | ||
| 11/11/2019 | Cellectis | CLLS | Maintain | Neutral (N/A) |
|
Details | ||
| 10/23/2019 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 10/22/2019 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2019 | Agios Pharma | AGIO | Maintain | Neutral (N/A) |
|
Details | ||
| 10/21/2019 | Acorda Therapeutics, Inc. | ACOR | Maintain | Sell (N/A) |
|
Details | ||
| 9/27/2019 | Atara Biotherapeutics | ATRA | Downgrade | Sell (Neutral) |
14.29 (16.04) |
12.25% | Details | |
| 9/27/2019 | Seattle Genetics | SGEN | Upgrade | Buy (Conviction Sell) |
73.62 (155.77) |
111.59% | Details | |
| 9/3/2019 | Vertex | VRTX | Upgrade | Conviction Buy (Buy) |
180.02 (192.87) |
7.14% | Details | |
| 8/20/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2019 | Cellectis | CLLS | Maintain | Neutral (N/A) |
|
Details | ||
| 7/23/2019 | Karuna Therapeutics Inc. | KRTX | New Coverage | Buy (N/A) |
19.69 (127.06) |
545.3% | Details | |
| 5/28/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2019 | Alexion Pharmaceuticals | ALXN | New Coverage | Neutral (N/A) |
128.80 (181.95) |
41.27% | Details | |
| 5/23/2019 | Vertex | VRTX | New Coverage | Buy (N/A) |
169.12 (180.02) |
6.45% | Details | |
| 5/23/2019 | Alnylam Pharmaceuticals | ALNY | New Coverage | Neutral (N/A) |
67.87 (175.61) |
158.74% | Details | |
| 5/23/2019 | Agios Pharma | AGIO | New Coverage | Neutral (N/A) |
51.36 (57.10) |
11.18% | Details | |
| 5/23/2019 | Blueprint Medicines | BPMC | New Coverage | Buy (N/A) |
78.97 (84.89) |
7.5% | Details | |
| 5/14/2019 | Solid Biosciences | SLDB | Downgrade | Sell (Neutral) |
8.85 (3.84) |
-56.61% | Details | |
| 5/7/2019 | GW Pharma | GWPH | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2019 | Precision BioSciences Inc. | DTIL | New Coverage | Buy (N/A) |
12.18 (5.27) |
-56.73% | Details | |
| 1/28/2019 | CRISPR Therapeutics | CRSP | Downgrade | Neutral (Buy) |
32.29 (137.06) |
324.47% | Details | |
| 1/15/2019 | Incyte | INCY | Upgrade | Conviction Buy (Buy) |
74.65 (99.37) |
33.11% | Details | |
| 1/2/2019 | Moderna | MRNA | New Coverage | Buy (N/A) |
15.27 (225.14) |
1374.39% | Details | |
| 12/26/2018 | Acorda Therapeutics, Inc. | ACOR | Maintain | Sell (N/A) |
|
Details | ||
| 12/19/2018 | Cellectis | CLLS | New Coverage | Neutral (N/A) |
17.71 (15.74) |
-11.12% | Details | |
| 12/11/2018 | Acorda Therapeutics, Inc. | ACOR | Downgrade | Sell (Neutral) |
18.63 (5.13) |
-72.46% | Details | |
| 11/5/2018 | Allogene | ALLO | New Coverage | Buy (N/A) |
26.95 (24.02) |
-10.87% | Details | |
| 9/21/2018 | bluebird bio | BLUE | Downgrade | Buy (Conviction Buy) |
141.30 (32.25) |
-77.18% | Details | |
| 9/19/2018 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (Buy) |
|
Details | ||
| 8/28/2018 | Ionis Pharmaceuticals | IONS | Maintain | Sell (Sell) |
|
Details |
